Digital PCR Market to Exhibit 17.2% CAGR by 2026 Owing to Improving Healthcare Facilities in Developing Nations, reports Fortune Business Insights™

    NEXT STORY
    Sun BioPharma Announces Pause in Enrollment of Clinical Trial of SBP-101 for Patients with Pancreatic Cancer
    PREV STORY
    SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    The global nephrology devices market accounted for $12,012 XX million in 2018, and is expected to reach $16,421 XX million by 2026, registering a CAGR of XX4.0% from 2019 to 2026

    author_avatar
    NASDAQ Market News

    Mateon Announces Issuance of US Patent for Cathepsin Inhibition

    SOUTH SAN FRANCISCO, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (Nasdaq:MATN), ...

    author_avatar
    NASDAQ Market News

    Sandoz presents new long-term and switching data for biosimilars Zessly® (infliximab) and Erelzi® (etanercept) in rheumatoid arthritis

    Zessly® (infliximab) matched the reference medicine in terms of safety and efficacy at 54 ...

    author_avatar
    NASDAQ Market News